8 patents
Utility
Anti-MUC1 antibody-drug conjugate
16 Jan 24
The present invention pertains to novel antibody drug conjugates (ADC) comprising anti-MUC1 antibody.
Johanna Gellert, Anke Flechner, Doreen Weigelt, Antje Danielczyk, Akiko Nagase
Filed: 1 Aug 22
Utility
Protein biomarker and uses thereof
16 Jan 24
The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as high.
Matthias Schneider, Sabine Blum, Renee Jeanne Mendell-Harary, Daniel J. Freeman, Robert Allen Beckman, Xiaoping Jin, Kimio Yonesaka, Kazuhiko Nakagawa
Filed: 21 Aug 19
Utility
Nucleic acid biomarker and use thereof
12 Dec 23
The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as high.
Matthias Schneider, Sabine Blum, Renee Jeanne Mendell-Harary, Daniel J. Freeman, Robert Allen Beckman, Xiaoping Jin
Filed: 21 Aug 19
Utility
ANTI-MUC1 Antibody-drug Conjugate
23 Nov 23
The present invention pertains to novel antibody drug conjugates (ADC) comprising anti-MUC1 antibody.
Johanna GELLERT, Anke FLECHNER, Doreen WEIGELT, Antje DANIELCZYK, Akiko NAGASE
Filed: 10 Jul 23
Utility
ANTI-MUC1 Antibody-drug Conjugate
4 May 23
The present invention pertains to novel antibody drug conjugates (ADC) comprising anti-MUC1 antibody.
Johanna GELLERT, Anke FLECHNER, Doreen WEIGELT, Antje DANIELCZYK, Akiko NAGASE
Filed: 1 Aug 22
Utility
ANTI-MUC1 Antibody-drug Conjugate
24 Jun 21
The present disclosure relates to antibody drug conjugates directed against the cancer antigen MUC1.
Johanna GELLERT, Anke FLECHNER, Doreen WEIGELT, Antje DANIELCZYK, Akiko NAGASE
Filed: 17 May 19
Utility
Nucleic Acid Biomarker and Use Thereof
6 May 20
The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at an mRNA level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at an mRNA level is assessed as high.
Matthias SCHNEIDER, Sabine BLUM, Renee Jeanne MENDELL-HARARY, Daniel J. FREEMAN, Robert Allen BECKMAN, Xiaoping JIN
Filed: 20 Aug 19
Utility
Protein Biomarker and Uses Thereof
15 Apr 20
The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as high.
Matthias SCHNEIDER, Sabine BLUM, Renee Jeanne MENDELL-HARARY, Daniel J. FREEMAN, Robert Allen BECKMAN, Xiaoping JIN, Kimio YONESAKA, Kazuhiko NAKAGAWA
Filed: 20 Aug 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first